GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 124 filers reported holding GOSSAMER BIO INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -40.0% | 4 | 0.0% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q4 2022 | $34,670 | -77.6% | 15,977 | +23.6% | 0.00% | -100.0% |
| Q3 2022 | $155,000 | +43.5% | 12,927 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $108,000 | -6.1% | 12,927 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $115,000 | -2.5% | 13,193 | +26.6% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | -9.9% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $131,000 | +54.1% | 10,421 | 0.0% | 0.00% | – |
| Q2 2021 | $85,000 | -11.5% | 10,421 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $96,000 | -5.0% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $101,000 | -21.7% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $129,000 | -4.4% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $135,000 | +365.5% | 10,421 | +264.8% | 0.00% | – |
| Q1 2020 | $29,000 | -35.6% | 2,857 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | – | 2,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |